Regulation of 5-HT1A and 5-HT1B receptor systems by phospholipid signaling cascades

被引:17
作者
Berg, KA [1 ]
Clarke, WP [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
关键词
cross-talk; phospholipase A(2); phospholipase C; pdenylyl cyclase;
D O I
10.1016/S0361-9230(01)00645-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The 5-HT1A and 5-HT1B receptor systems play central roles in the control of serotonergic neurotransmission and feature prominently in many behaviors and physiological functions. In addition, the regulation of these receptors and their effector mechanisms has been the focus of intense interest because of their potential importance in the therapeutic actions of anxiolytic and antidepressant drugs. Here we describe the regulation of 5-HT1A and 5-HT1B receptor-mediated inhibition of adenylyl cyclase activity by receptors which activate phospholipid signaling cascades. Although it might be expected that these two highly homologous Gi-coupled receptors would be regulated similarly by activation of phospholipase C (PLC) and phospholipase A(2) (PLA(2)), we have found that the regulation differs markedly between these receptor systems. Further, our data suggest that the modulation of agonist efficacy at these receptor subtypes is dependent on the nature of receptor coupling to PLC and PLA(2) activation. Moreover, regulation at the level of the effector (e.g., adenylyl cyclase) appears to play a significant role in the regulation of both the 5-HT1A and 5-HT1B receptor systems by the PLA(2) signaling cascade. Such data illustrate multiple levels for control of biochemical signaling cascades within cells and demonstrate that although different receptors may couple to the same effector pathways, the ultimate cellular effects produced by these receptors may differ due to differential cross-talk regulation. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 28 条
[1]   A-G PROTEIN COUPLES SEROTONIN AND GABA-B RECEPTORS TO THE SAME CHANNELS IN HIPPOCAMPUS [J].
ANDRADE, R ;
MALENKA, RC ;
NICOLL, RA .
SCIENCE, 1986, 234 (4781) :1261-1265
[2]  
BERG KA, 1994, MOL PHARMACOL, V45, P826
[3]  
BERG KA, 1994, MOL PHARMACOL, V46, P477
[4]   Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Clarke, WP .
ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 :104-110
[5]   Interactions between effectors linked to serotonin receptors [J].
Berg, KA ;
Maayani, S ;
Clarke, WP .
ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 :111-120
[6]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[7]  
Berg KA, 1996, MOL PHARMACOL, V50, P1017
[8]   Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders [J].
Blier, P ;
de Montigny, C .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :S91-S98
[9]  
BOULEHAL R, 1988, EUR J PHARMACOL, V151, P189
[10]   INHIBITION OF FORSKOLIN-STIMULATED ADENYLATE-CYCLASE ACTIVITY BY 5-HT RECEPTOR AGONISTS [J].
DEVIVO, M ;
MAAYANI, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 119 (03) :231-234